anemodeanin a has been researched along with oleanolic acid in 2 studies
Studies (anemodeanin a) | Trials (anemodeanin a) | Recent Studies (post-2010) (anemodeanin a) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
29 | 0 | 27 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | anemodeanin a (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, LS; Wu, FE; Xiao, XH; Zhang, LD; Zheng, RL; Zhu, ZQ | 1 |
Chang, HW; Jin, UH; Kim, CH; Kim, KW; Lee, SH; Lee, YC; Son, JK; Son, KH; Suh, SJ | 1 |
2 other study(ies) available for anemodeanin a and oleanolic acid
Article | Year |
---|---|
[Effects of anemodeanin A on DNA, RNA and protein of tumor cells in vitro and plasma cAMP in mice].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Cyclic AMP; DNA, Neoplasm; Female; Male; Mice; Neoplasm Proteins; Neoplasms, Experimental; Oleanolic Acid; RNA, Neoplasm; Sapogenins; Sarcoma 180 | 1985 |
Triterpenoid saponin, oleanolic acid 3-O-beta-d-glucopyranosyl(1-->3)-alpha-l-rhamnopyranosyl(1-->2)-alpha-l-arabinopyranoside (OA) from Aralia elata inhibits LPS-induced nitric oxide production by down-regulated NF-kappaB in raw 264.7 cells.
Topics: Animals; Aralia; Cell Line; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Inflammation Mediators; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oleanolic Acid | 2007 |